Absorbable adhesion barrier gel based on hyaluronic acid technology for surgical applications. Reduces post-operative tissue adhesion formation following abdominal and pelvic procedures. Cross-linked hyaluronic acid formulation provides biocompatibility and complete resorption within 7-14 days.
Manufactured by
SciVision Biotech Inc.
Kaohsiung, Taiwan
SciVision Biotech Inc., established in 2001, is a publicly listed company on the Taiwan Stock Exchange since 2013 (Stock Code: 1786). We specialize in the development and manufacturing of premium medical-grade hyaluronic acid products. At SciVision Biotech Inc., we take pride in our self-developed and patented technologies, including the Crosslinked Hyaluronic Acid Platform (CHAP) and auto cross-linking technology. Through these in-house innovations, we have achieved precise control over the characteristics of hyaluronic acid, setting a new industry standard. Our patented auto cross-linking technology represents a breakthrough that eliminates the need for chemical cross-linking agents, positioning SciVision as the only company in the world capable of producing medical-grade crosslinked hyaluronic acid products without adding chemicals. This unique capability allows us to offer a broad portfolio of cross-linking hyaluronic acid products with diverse forms and physical properties.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Samyang Biopharm Corporation
South Korea · 1 relevant product
BioRegen Biomedical (Changzhou) Co. Ltd.
China · 1 relevant product
Jiangxi Borayer Biotechnology Co., Ltd
China · 2 relevant products
58 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →13 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 84 closest product alternatives
Samyang Biopharm Corporation · South Korea
Absorbable adhesion barrier designed to prevent post-surgical tissue adhesions following abdominal and pelvic procedures. This consumable device is placed at the surgical site to create a physical barrier that gradually absorbs as tissue heals, reducing complications from unwanted scar tissue formation.
BioRegen Biomedical (Changzhou) Co. Ltd. · China
Absorbable adhesion barrier gel for obstetric and gynecological surgery, designed to reduce post-operative tissue adhesions. Formulated with self-crosslinked biomimetic materials that promote natural wound healing. Applied topically during surgery to create a physical barrier between damaged tissues, facilitating restoration of normal tissue function.
Jiangxi Borayer Biotechnology Co., Ltd · China
Bioengineered membrane designed to prevent post-surgical tissue adhesions. Separates tissue surfaces during healing while being gradually resorbed. Applied during abdominal, gynecological, and orthopedic procedures.
81 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products